Resources

Publications and guidelines

669 publications

Guidance documents, forms, circulars and reports issued by the Authority.

MADRAC Bulletin

New Publication: MADRAC Bulletin - Issue 1/2017

MADRAC Bulletin - Issue 01/2017 Features ▪ Cyclopentolate Eye Drops Use in Premature Infants: Risk of Respiratory Adverse Events ▪ Colchicine: Reminder on the Risk of Toxicity▪ Summary of Safety…

Document attached

REAKSI Drug Safety News

New Publication: Reaksi Drug Safety News - Issue 4/2017

REAKSI Drug Safety News, Issue 4/2017, Vol. 36 Hyoscine Butylbromide Injection: Risk of Serious Adverse Effects in Patients with Underlying Cardiac Disease Keytruda® (pembrolizumab): Risk of…

Document attached

REAKSI Drug Safety News

New Publication: Reaksi Drug Safety News - Issue 3/2017

REAKSI Drug Safety News, Issue 3/2017 Loperamide: Risk of Serious Cardiac Adverse Events with High Doses, Including Through Misuse Thalidomide, Lenalidomide and Pomalidomide: Risk of Hepatitis B…

Document attached

REAKSI Drug Safety News

New Publication: Reaksi Drug Safety News - March 2017

REAKSI Drug Safety News, No. 34, March 2017 Interferon alfa & Interferon beta: Risk of Pulmonary Arterial Hypertension Fluconazole: Caution in Use During Pregnancy DOWNLOAD PDF

Document attached

English

New Products Approved

Year 2026 DCA422Senarai produk yang diluluskan dalam PBKD 422 7 Julai 2026 DCA421Senarai produk yang diluluskan dalam PBKD 421 8 Jun 2026 DCA420Senarai produk yang diluluskan dalam PBKD 420 7 Mei…

Document attached

MADRAC Bulletin

New Publication: Bulletin MADRAC - December 2016

MADRAC Bulletin - December 2016 Regulatory Matters ▪ Olanzapine: Risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)▪ Codeine: Risk of respiratory depression▪ Warfarin: Rare cases…

Document attached